Scott is the CEO of Zoe Biosciences and a former Advisor to Sergey Young’s Longevity Vision Fund. Scott’s mission is to advance biology that helps patients get more out of life. To that end, he helped build the Flow Research Collective, a company studying the neuroscience of peak performance, as the Head of Business Development & Strategic Partnerships, and worked on the scientific diligence team at OS Fund, a deep tech-focused VC firm. Scott’s research experience spans epigenetics/genetics work studying tandem repeats (Sharp Lab at Mount Sinai), cognition research in octopuses (Tse Lab at Dartmouth), in silico autism research (In Silico Biosciences), and marine biology conservation work in Madagascar. He holds a Bachelor’s in Neuroscience from Dartmouth and a Master’s in Biotechnology from Johns Hopkins.
Our Team
Core Team

Scott Gies
CEO